Skip to main content
. Author manuscript; available in PMC: 2020 Sep 2.
Published in final edited form as: Cancer Prev Res (Phila). 2017 Nov 22;11(2):113–119. doi: 10.1158/1940-6207.CAPR-17-0245

Table 4.

Association between CLS-B and BMI

N (%) with any CLS-B Overall
N = 250
KTB
n = 86
BBD controls
n = 81
BBD cases
n = 83
BMI < 25 6/86 (7.0%) 0/24 2/32 (6.3%) 4/30 (13.3%)
BMI 25–29 11/88 (12.5%) 1/30 (3.3%) 2/25 (8.0%) 8/33 (24.2%)
BMI ≥ 30 22/76 (28.9%) 2/32 (6.3%) 11/24 (45.8%) 9/20 (45.0%)